Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.
Silvia SchmidtovaLambert C J DorssersKatarina KalavskaAd J M GillisJ Wolter OosterhuisHans StoopSvetlana MiklikovaZuzana KozovskaMonika BurikovaKatarina GercakovaErika DurinikovaMichal ChovanecMichal MegoLucia KucerovaLeendert H J LooijengaPublished in: Cancer cell international (2020)
The novel chemoresistant cells represent unique model of refractory oYST. CSC markers are associated with cisplatin resistance being possible targets in chemorefractory oYST.